Global Health EDCTP3 2024 Work Programme and Info day
Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) recently published its 2024 Work Programme.
The Joint Undertaking works to deliver new solutions to reduce the burden of infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases.
In 2024, €140 million will be disbursed through 7 different funding opportunties focusing on:
- Novel, innovative HIV therapeutics
- Research on existing malaria vaccines and new candidates
- Development of therapeutics and NPIs against Neglected Tropical Diseases
- Tackling AMR through R&D in antimicorbials
- New tools for vector control
- Digital health solutions
- Academia/industry fellowships
All the EDCTP3 open calls can be found here.
On Tuesday 6 February the European Commission organises an Info day where the different funding opportunities under the 2024 Work Programme will be presented and this will be followed by a Questions and Answers (Q&A) sessions with the audience.
This might also interest you
See all
Calls
2 new calls | EP PerMed (the European Partnership for Personnalised Medicine)
2 new calls dedicated to accelerating research and innovation in Personnalised Medicine
Calls
Transformative Health Instrument Call 2025 – EIT Health
Aimed at start-ups which are focused on creating adaptable innovations that ensure healthcare delivery becomes more personalised, sustainable, and effective.
EIT
EIT Health’s Deep Tech Venture Builder Programme
Deadline for the call: December 16th
